
CAS: 1613200-51-3
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
![]() | Tuvusertib REF: 54-BUP02405CAS: 1613200-51-3 | 99.66% | 704,00 €~1.260,00 € | Mer 16 Apr 25 |
![]() | 2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide REF: 3D-NPC20051CAS: 1613200-51-3 | Min. 95% | Prezzo su richiesta | Mar 27 Mag 25 |
![]() | Tuvusertib REF: TM-T10406CAS: 1613200-51-3 | 99.66% | 74,00 €~930,00 € | Mar 15 Lug 25 |

Ref: 54-BUP02405
25mg | 704,00 € | ||
50mg | 965,00 € | ||
100mg | 1.260,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 16 Aprile 2025

2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CAS:1613200-51-3
Please enquire for more information about 2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide including the price, delivery time and more detailed …
Formula:
C16H12F2N8O
Purezza:
Min. 95%
Peso molecolare:
370.32 g/mol
Ref: 3D-NPC20051
5mg | 1.526,00 € | ||
10mg | 2.378,00 € | ||
25mg | 4.458,00 € | ||
50mg | 7.132,00 € |
Consegna stimata in Stati Uniti, il Martedì 27 Maggio 2025

Tuvusertib
CAS:1613200-51-3
Tuvusertib (M1774), an oral ATR inhibitor (Ki<1µM), selectively blocks CHK1 phosphorylation, disrupts DNA repair, …
Formula:
C16H12F2N8O
Purezza:
99.66%
Colore e forma:
Solid
Peso molecolare:
370.32
Ref: TM-T10406
1mg | 74,00 € | ||
5mg | 162,00 € | ||
10mg | 245,00 € | ||
25mg | 472,00 € | ||
50mg | 657,00 € | ||
100mg | 930,00 € | ||
1mL*10mM (DMSO) | 177,00 € |
Consegna stimata in Stati Uniti, il Martedì 15 Luglio 2025